Alemtuzumab induction versus conventional immunosuppression in heart transplant recipients

被引：0
|
作者：
Leelathanalerk, Areerut [1 ]
Ingviya, Thammasin [2 ]
Ivaturi, Vijay [1 ]
Reed, Brent N. [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA
来源：
PHARMACOTHERAPY | 2015年 / 35卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
451
引用
收藏
页码：E292 / E293
页数：2
相关论文
共 50 条
  • [31] Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients
    Shaker, T.
    Ramanathan, K.
    Riad, S.
    Vock, D.
    Chinnakotla, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 511 - 512
  • [32] Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients
    Teebken, OE
    Strüber, M
    Harringer, W
    Pichlmaier, MA
    Haverich, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (04) : 1265 - 1268
  • [33] Evaluation of a Three-Dose Basiliximab Induction Immunosuppression Regimen in Adult Heart Transplant Recipients
    Donohue, L.
    Ally, W.
    Dunn, S.
    Kennedy, J.
    Bergin, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [34] Single Drug Immunosuppression for Infant Heart Transplant Recipients
    Stack, S. M.
    Eshelman, J.
    Pietra, B. A.
    Miyamoto, S. D.
    Auerbach, S. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S322 - S323
  • [35] The need for a tailored immunosuppression in older heart transplant recipients
    Kaczmarek, I
    Sadoni, S
    Schmoeckel, M
    Lamm, P
    Daebritz, S
    Veberfuhr, P
    Meiser, B
    Reichart, B
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11): : 1965 - 1968
  • [36] Sparing immunosuppression in heart transplant recipients with severe sepsis
    Chou, N. K.
    Ko, W. J.
    Chi, N. H.
    Chen, Y. S.
    Yu, H. Y.
    Hsu, R. B.
    Fang, C. T.
    Chang, S. C.
    Lin, F. Y.
    Chu, S. H.
    Wang, S. S.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2145 - 2146
  • [37] Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
    Hurst, Frank P.
    Altieri, Maria
    Nee, Robert
    Agodoa, Lawrence Y.
    Abbott, Kevin C.
    Jindal, Rahul M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (06) : 534 - 541
  • [38] Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy
    Bosch, W.
    Poowanawittayakom, N.
    Chaikriangkrai, K.
    Mendez, J.
    Hellinger, W. C.
    Gonwa, T. A.
    Krishna, M.
    Pungpapong, S.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : E33 - E39
  • [39] Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients
    Sung, Jennifer
    Barry, John M.
    Jenkins, Randy
    Rozansky, David
    Iragorri, Sandra
    Conlin, Michael
    Al-Uzri, Amira
    PEDIATRIC TRANSPLANTATION, 2013, 17 (08) : 718 - 725
  • [40] Immune Profile of Pediatric Renal Transplant Recipients following Alemtuzumab Induction
    De Serres, Sacha A.
    Mfarrej, Bechara G.
    Magee, Ciara N.
    Benitez, Fanny
    Ashoor, Isa
    Sayegh, Mohamed H.
    Harmon, William E.
    Najafian, Nader
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01): : 174 - 182
12345